Pathstone Family Office’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.7M | Buy |
4,521
+491
| +12% | +$184K | 0.01% | 503 |
|
|
2023
Q2 | $1.56M | Buy |
4,030
+231
| +6% | +$89.4K | 0.02% | 366 |
|
|
2023
Q1 | $1.32M | Sell |
3,799
-13,761
| -78% | -$4.77M | 0.02% | 374 |
|
|
2022
Q4 | $2.97M | Buy |
17,560
+10,508
| +149% | +$1.78M | 0.03% | 394 |
|
|
2022
Q3 | $1.73M | Buy |
7,052
+3,975
| +129% | +$978K | 0.02% | 492 |
|
|
2022
Q2 | $931K | Sell |
3,077
-1,897
| -38% | -$574K | 0.02% | 361 |
|
|
2022
Q1 | $2.04M | Sell |
4,974
-312
| -6% | -$128K | 0.05% | 172 |
|
|
2021
Q4 | $2.48M | Buy |
5,286
+542
| +11% | +$254K | 0.06% | 156 |
|
|
2021
Q3 | $2.01M | Buy |
4,744
+292
| +7% | +$124K | 0.06% | 168 |
|
|
2021
Q2 | $1.6M | Buy |
4,452
+3,119
| +234% | +$1.12M | 0.05% | 181 |
|
|
2021
Q1 | $376K | Buy |
+1,333
| New | +$376K | 0.01% | 414 |
|